Company intelligence / Profile preview

Verispan

Yardley, Pennsylvania, United States

Ownership: Private
Employees: ~500
Development stage: Other

Overview

Verispan was a leading provider of healthcare information and market research services, specializing in longitudinal patient data and pharmaceutical tracking. Formed in 2002 as a joint venture between Quintiles Transnational and McKesson, the company provided critical insights into physician prescribing patterns and patient treatment flows. Its products, such as the Vector One database, were widely used by pharmaceutical companies for sales force optimization and market analysis. Verispan was acquired by SDI Health in 2008, which was subsequently integrated into IMS Health (now IQVIA). The company's data assets remain foundational to modern pharmaceutical market intelligence.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

McKessonQuintiles Transnational

Beyond the preview

Go deeper on Verispan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Verispan.

Explore the full profile